Rare diseases
Investigational molecules
Locations
Back to Austria363 clinical trials in Innsbruck, Austria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
AustriaA study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
AustriaStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
AustriaA Phase 3 Study of GSK5733584 with drug combination in patients with platinum‑resistant ovarian cancer
AustriaStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
AustriaLong‑Term Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease
AustriaAustriaComparison of dupilumab and tezepelumab for the treatment of chronic rhinosinusitis with nasal polyps.
AustriaAustriaA Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma
AustriaAustriaStudy of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6
AustriaThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on innovative treatments for various cancers, including bladder cancer, breast cancer, and gastric cancer. Studies evaluate novel combination therapies and targeted treatments to improve patient outcomes.
Research emphasizes personalized medicine approaches and innovative drug combinations.
Groundbreaking studies examining treatments for multiple sclerosis and other neurological conditions. Research focuses on testing new therapeutic agents and evaluating their effectiveness in managing disease progression.
Trials aim to advance understanding of disease mechanisms and improve treatment outcomes.
Clinical investigations into chronic inflammatory diseases, including Crohn's Disease and ulcerative colitis. Studies evaluate novel therapeutic approaches and combination treatments.
Research focuses on improving quality of life for patients with chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
